Table 2: Patient count of those who underwent therapies and the outcomes of treatment.
|
Group A pre-COVID-19 testing (patients) no. |
Group B symptomatic COVID-19 (patients) no. |
Group C asymptomatic COVID-19 (patients) no. |
Group D Pre-symptomatic COVID-19 (patients) no. |
Antibiotics |
15 |
13 |
0 |
1 |
Oxygen |
14 |
7 |
3 |
2 |
Volume resuscitation |
12 |
2 |
1 |
1 |
Steroids |
10 |
8 |
1 |
2 |
Heparin (LMWH) |
1 |
13 |
2 |
0 |
Hydroxycloroquine |
0 |
7 |
0 |
0 |
Morphine |
10 |
2 |
0 |
1 |
midazolam |
1 |
0 |
0 |
1 |
Outcome · Death in LTCF · Survivors in LTCF · Transfer to acute-care setting
|
18 0
0 |
3 16
0 |
0 9
1 |
2 0
0 |